Paratek's Omadacycline Get US Panel OK, But CABP Mortality Remains Concern

 
• By Derrick Gingery
  
Dart arrow hitting in the target center of dartboard using as background Target business, achieve and victory,success concept.

More from US FDA Performance Tracker

More from Regulatory Trackers